Breaking News
September 25, 2018 - Hybrid theranostic complex shows high therapeutic efficacy against tumor cells
September 25, 2018 - FDA Issues Statement Reaffirming the Positive Benefit-Risk Profile of Nuplazid (pimavanserin) for Patients with Hallucinations and Delusions Associated with Parkinson’s Disease Psychosis
September 25, 2018 - 5 obstacles parents commonly face in child obesity treatment and how to overcome them
September 25, 2018 - Immunologist to study how Chikungunya causes devastating effects in older adults
September 25, 2018 - Rural borderland communities vulnerable to high stress impacting mental and physical health
September 25, 2018 - SNMMI announces recipients of 2018-2020 Wagner-Torizuka Fellowship
September 25, 2018 - Common painkiller not effective in controlling chronic pain after traumatic nerve injury
September 25, 2018 - New therapeutic vaccine helps immune cells fight HPV-related head and neck cancer
September 25, 2018 - Environmentally-induced gene activity influences IQ test performance
September 25, 2018 - Biogen and Eisai announce results of LTE Phase 1b study of aducanumab for treating MCI
September 25, 2018 - FDA Approves Copiktra (duvelisib) Capsules for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma and Follicular Lymphoma
September 25, 2018 - Medical device company settles US case over false claims
September 25, 2018 - Trying to get answers: One woman’s quest for a diagnosis
September 25, 2018 - Lung cancer patients treated with invasive surgery more likely to become chronic opioid users
September 25, 2018 - Oxford VR raises £3.2m to boost innovation in VR for mental health problems
September 25, 2018 - Gene therapy approach could help treat mitochondrial diseases
September 25, 2018 - Few Yogurt Products Qualify As Low-Sugar
September 25, 2018 - Eye disease can cause blindness, and it’s on the rise
September 25, 2018 - Pawnshop density linked to gun-related suicides, Stanford study finds
September 25, 2018 - Pioneering procedure for common prostate condition offered by The London Clinic
September 25, 2018 - Number of people with respiratory diseases likely to increase if UK air pollution remains unchecked
September 25, 2018 - FARXIGA receives positive results in Phase III DECLARE-TIMI 58 cardiovascular outcomes trial
September 25, 2018 - New program to reduce harmful stress effectively improves mood in cancer patients
September 24, 2018 - Florence’s Lingering Threat: Mold – Drugs.com MedNews
September 24, 2018 - For professional baseball players, faster hand-eye coordination linked to batting performance
September 24, 2018 - Bill for later school start times is defeated, but Stanford sleep specialist isn’t
September 24, 2018 - For Heart Failure Patients, Mitral Valve Procedure Improved Outcomes
September 24, 2018 - Successful recovery from addiction means more than achieving abstinence
September 24, 2018 - New nanoplatform technology may reverse drug-resistance in renal cell carcinoma
September 24, 2018 - October 1918 marks the centenary of Spanish Flu that claimed more lives than World War I
September 24, 2018 - LGBT community reports more number of poor mental health days than general population
September 24, 2018 - New research suggests power of zebrafish as tool for cancer drug discovery
September 24, 2018 - New study finds height as possible risk factor for developing varicose veins
September 24, 2018 - Researchers compare weight loss results of online and in-person diabetes prevention program
September 24, 2018 - New HER2 PET Study Uses Affibody’s ABY-025 Tracer to Individualize Breast Cancer Treatment
September 24, 2018 - Drug combination offers more effective care for patients suffering miscarriage
September 24, 2018 - Tallness linked to varicose veins, Stanford study says
September 24, 2018 - For Heart Failure Patients, Mitral Valve Procedure Improved Outcomes
September 24, 2018 - Ecstasy drug makes octopuses more social
September 24, 2018 - Immediate compression therapy could cut risk of complications after deep-vein thrombosis
September 24, 2018 - Transcatheter mitral valve repair reduces mortality for patients with mitral regurgitation
September 24, 2018 - First intracranial aneurysm patients treated with BRAVO Flow Diverter after CE mark approval
September 24, 2018 - ‘Physicians of the mouth’? Dentists absorb the medical billing drill
September 24, 2018 - People more likely to believe those with confident tone of voice than with accent
September 24, 2018 - Harmony Biosciences Presents 5-Year Data On Pitolisant At International Narcolepsy Symposium
September 24, 2018 - Blood test may identify gestational diabetes risk in first trimester
September 24, 2018 - Height may be risk factor for varicose veins | News Center
September 24, 2018 - King’s commemorates opening of new NMR facility with one-day symposium
September 24, 2018 - Eisai receives approval for partial label change of DC Bead device for transcatheter arterial embolization
September 24, 2018 - Using multi-level approach to reduce underage drinking among youths on rural reservations
September 24, 2018 - High-resolution genomic map gives scientists unprecedented view of brain development
September 24, 2018 - Researchers find impact of neurobehavioral symptoms on employment in adults with TBI
September 24, 2018 - Alexion announces positive results from Phase 3 PREVENT study of Soliris in patients with NMOSD
September 24, 2018 - First evaluation of benefits, harms of Alzheimer’s screening for family members of older adults
September 24, 2018 - Ancora Heart announces positive data of study evaluating AccuCinch Ventricular Repair System
September 24, 2018 - Children of mothers using cannabis may start using it at an earlier age, finds study
September 24, 2018 - Gilead Sciences plans to launch authorized generic versions of Epclusa and Harvoni in the US
September 24, 2018 - Most patients who underwent transcatheter valve replacement experience prosthesis-patient mismatch
September 24, 2018 - Lumos acquires license for LUM-201 drug that promotes secretion of growth hormone
September 24, 2018 - New study provides basis for Air Canada to change its facial hair policy for aircrew
September 24, 2018 - Infant walkers lead to thousands of emergency visits for babies
September 24, 2018 - Genes predicting person’s height may provide clues about causes of varicose veins
September 24, 2018 - EPA Plan Will Maintain Carbon Emissions From Power Plants
September 24, 2018 - Characterizing pig hippocampus could improve translational neuroscience
September 24, 2018 - Element3 Health reports social and mental engagement play key role in overall health
September 24, 2018 - Paralympic medalists support Fight for Sight’s unique virtual event
September 24, 2018 - ADCETRIS drug receives approval in Japan as frontline treatment option for Hodgkin lymphoma
September 24, 2018 - Public awareness of urological conditions found to be alarmingly low across Europe
September 24, 2018 - Fitter Folks Suffer Milder Strokes: Study
September 24, 2018 - Novel botulinum toxin compound relieves chronic pain
September 24, 2018 - CHMP recommends approval of Gilenya for treatment of multiple sclerosis in children, adolescents
September 24, 2018 - National Friendly’s private medical insurance is a hit with women living in the South East
September 24, 2018 - Academics receive prestigious awards for achievements in blood pressure research
September 24, 2018 - Obese pregnant women can restrict weight gain safely with proper nutrition guidance
September 24, 2018 - CHMP adopts positive opinion of Takeda’s ALUNBRIG for treatment of ALK+ non-small cell lung cancer
September 24, 2018 - China NMPA approves LENVIMA for treatment of unresectable hepatocellular carcinoma
September 24, 2018 - A new approach for finding Alzheimer’s treatments
September 24, 2018 - USC research uncovers previously unknown genetic risk factor for dementia
September 24, 2018 - Study examining mental health among students finds significant disparities in treatment across race
September 24, 2018 - Breakthrough discovery paves way for future test to identify drowsy drivers
Researchers working to develop new system for early prostate cancer diagnosis

Researchers working to develop new system for early prostate cancer diagnosis

image_pdfDownload PDFimage_print

Researchers of the Universitat Politècnica de València and the Universidad de Granada, together with doctors from the Hospital Clínic Universitari de València are working on the development of a new system to help diagnose prostate cancer. The work being developed is part of the SICAP project.

Heretofore, researchers have already developed an online application that helps pathologists evaluate samples obtained in biopsies, as well as an initial version of the system that is capable of establishing whether the samples are carcinogenic or not.

The website is a tool ‘of great use’ for an initial evaluation of patients’ histopathological samples, as it allows pathologists to analyze the image of each sample. “After loading the – high resolution – images onto the system, they can be magnified without losing resolution, which makes for an improved, and specially easier and more comfortable, analysis of each sample. Pathologists can draw on the image, marking the affected areas and indicating the Gleason grading system level observed in each area. This written data is what will then be taken into account by our system,” explains Valery Naranjo, coordinator of the Computer Vision and Behaviour Analysis Lab-I3B of the Universitat Politècnica de València.

Meanwhile, on the first version of the system, Naranjo outlines the fact that it can extract new features from which to tell carcinogenic cells from healthy ones with 95% sensitivity and 99% specificity. Work is now centered on training the system to not only detect carcinogenic samples but also indicate the stage of the cancer.

Prostate cancer and its detection

Prostate cancer is the most common cause of death among men over 70 and the average age of diagnosis is 66. A majority of cases – 92% – are detected when the illness is already located in the prostate gland or neighboring organs.

The procedure to obtain the diagnosis of this illness starts with a visit to the urologist, with a clinical interview, physical exploration and, if relevant, a request for a blood test to check for the presence of prostate-specific antigen (PSA).

“This technique has increased the ability to detect this illness among population at risk. However, the determining test for its diagnosis is a prostate biopsy, as PSA is unspecific and leads to a large amount of false positives,” Valery Naranjo adds.

A faster and more precise and objective diagnosis

According to María Angeles Sales Maicas, from the Hospital Clínic Universitari de València’s Department of Pathologic Anatomy, all biopsy samples obtained by the urologist are processed in the lab for a subsequent analysis and evaluation by the pathologist by means of optical microscopy. “It is the pathologist who determines whether there is cancer or not, and if there is, he determines the stage of the cancer thanks to the Gleason scale, which is used to establish a prognosis. This scale has five levels and its use is subjective, which makes its reproducibility harder, specially in stages 3 and 4,” adds Dr Sales.

The system created as part of the SICAP project will make it possible to automatically segment images of the histopathological samples obtained in prostate biopsies, as well as to extract features based on the tissue’s structure. “It would be the extraction of these features which would help pathologists diagnose and evaluate tumors, as well as to classify them more objectively, specially in stages 3-4,” adds Dr Francisco García Morata, from the Urology Department at the Hospital Clínic Universitari de València.

Therefore, the SICAP system will not substitute the pathologist, but instead get rid of a majority of the subjectivity that comes with the analysis of this type of samples, giving the urologist more robust information to determine the tumor’s aggressiveness as well as the patient’s prognosis. This will in turn allow us to establish therapeutic options that are more appropriate for each type of tumor. “It can be specially useful in smaller hospitals, where a reduced number of pathologists prevents their sub-specialization, which decreases the precision when it comes to making a subjective analysis of biopsy samples,” says Dr José Mª Martínez Jabaloyas, from the Urology Department at the Hospital Clínic Universitari de València.

Furthermore, the system adds a series of self-learning algorithms, so that for every new case, it will automatically compare the features of the samples currently being analyzed with those registered previously, making diagnosis easier and faster.

Rafael Molina, researcher for the Department of Computer Sciences and Artificial Intelligence at the Universidad de Granada, explains that this system, which is currently based on extracting morphological features from histological images in order to then classify them using Gaussian processes, will soon add the unsupervised collection of hematoxylin and eosin stains as well as the automatic mining of relevant features from said images by using Deep Learning techniques.

Source:

New system facilitates early prostate cancer detection

Tagged with:

About author

Related Articles